Edward Nirenberg on Nostr: The balance of benefits and harms here is... challenging. There are 9 studies that ...
The balance of benefits and harms here is... challenging. There are 9 studies that inform the question but most are small, and they focus on immunogenicity instead of clinical outcomes. There is no consideration of recombinant vaccines.
Published at
2024-06-27 17:13:38Event JSON
{
"id": "bc384dd7c9d091f53dee0a84a5828464a5c13d49feb42da5b5213547437b94ae",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1719508418,
"kind": 1,
"tags": [
[
"e",
"9db0fe9f355a41898bb23e047d2b8bd18945db5bc7e6cbefca5a87bad8505239",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112689703694420336",
"activitypub"
]
],
"content": "The balance of benefits and harms here is... challenging. There are 9 studies that inform the question but most are small, and they focus on immunogenicity instead of clinical outcomes. There is no consideration of recombinant vaccines.\n\nhttps://cdn.masto.host/medmastodoncom/media_attachments/files/112/689/703/589/078/877/original/96e9f6c61ec5bda4.png",
"sig": "b7596e77094bcd28248528b29c8f53e057249125d92ab462855e63c80fb73e76c58b2cef311378441ad071632ca721d92cb001ee5f2990ba47374728f385d56e"
}
